Supplementary Figure S1 from ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin

Authors: Misty D. Shields, Katherine G. Minton, Hilal Ozakinci et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>The top hits by tandem mass tag (TMT)-labeled proteomics from the lurbinectedin sensitive cohort were evaluated for pathway enrichment based on ISL1 “high” versus ISL1 “low” signature. Gene Ontology (GO) analysis displays the most common pathways associated with the 142 proteins selected based on the threshold of |log2 ratio| >0.9 and P < 0.05.</p></jats:p>

Keywords

based isl1 pthe hits tandem

Supplementary Figure S1 from ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin

Abstract

Keywords

Related Articles

Supplementary Table S8 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Supplementary Figure S9 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Figure S8 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer

Table S11 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma

Table S1 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma